286 related articles for article (PubMed ID: 25864708)
1. Celiac disease 2015 update: new therapies.
Veeraraghavan G; Leffler DA; Kaswala DH; Mukherjee R
Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):913-27. PubMed ID: 25864708
[TBL] [Abstract][Full Text] [Related]
2. Novel Nondietary Therapies for Celiac Disease.
Alhassan E; Yadav A; Kelly CP; Mukherjee R
Cell Mol Gastroenterol Hepatol; 2019; 8(3):335-345. PubMed ID: 31146067
[TBL] [Abstract][Full Text] [Related]
3. Novel therapeutic approaches for celiac disease.
Vanga RR; Kelly CP
Discov Med; 2014 May; 17(95):285-93. PubMed ID: 24882720
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological approaches in celiac disease.
McCarville JL; Caminero A; Verdu EF
Curr Opin Pharmacol; 2015 Dec; 25():7-12. PubMed ID: 26414923
[TBL] [Abstract][Full Text] [Related]
5. Advances in understanding the potential therapeutic applications of gut microbiota and probiotic mediated therapies in celiac disease.
Francavilla R; Cristofori F; Vacca M; Barone M; De Angelis M
Expert Rev Gastroenterol Hepatol; 2020 May; 14(5):323-333. PubMed ID: 32216476
[TBL] [Abstract][Full Text] [Related]
6. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study.
Kelly CP; Green PH; Murray JA; Dimarino A; Colatrella A; Leffler DA; Alexander T; Arsenescu R; Leon F; Jiang JG; Arterburn LA; Paterson BM; Fedorak RN;
Aliment Pharmacol Ther; 2013 Jan; 37(2):252-62. PubMed ID: 23163616
[TBL] [Abstract][Full Text] [Related]
7. New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options.
Segura V; Ruiz-Carnicer Á; Sousa C; Moreno ML
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34201435
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge.
Leffler DA; Kelly CP; Abdallah HZ; Colatrella AM; Harris LA; Leon F; Arterburn LA; Paterson BM; Lan ZH; Murray JA
Am J Gastroenterol; 2012 Oct; 107(10):1554-62. PubMed ID: 22825365
[TBL] [Abstract][Full Text] [Related]
9. Potential therapeutic options for celiac Disease: An update on Current evidence from Gluten-Free diet to cell therapy.
Noori E; Hashemi N; Rezaee D; Maleki R; Shams F; Kazemi B; Bandepour M; Rahimi F
Int Immunopharmacol; 2024 May; 133():112020. PubMed ID: 38608449
[TBL] [Abstract][Full Text] [Related]
10. Current pharmacological approaches and potential future therapies for Celiac disease.
Kulkarni A; Patel S; Khanna D; Parmar MS
Eur J Pharmacol; 2021 Oct; 909():174434. PubMed ID: 34418405
[TBL] [Abstract][Full Text] [Related]
11. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
Comino I; Fernández-Bañares F; Esteve M; Ortigosa L; Castillejo G; Fambuena B; Ribes-Koninckx C; Sierra C; Rodríguez-Herrera A; Salazar JC; Caunedo Á; Marugán-Miguelsanz JM; Garrote JA; Vivas S; Lo Iacono O; Nuñez A; Vaquero L; Vegas AM; Crespo L; Fernández-Salazar L; Arranz E; Jiménez-García VA; Antonio Montes-Cano M; Espín B; Galera A; Valverde J; Girón FJ; Bolonio M; Millán A; Cerezo FM; Guajardo C; Alberto JR; Rosinach M; Segura V; León F; Marinich J; Muñoz-Suano A; Romero-Gómez M; Cebolla Á; Sousa C
Am J Gastroenterol; 2016 Oct; 111(10):1456-1465. PubMed ID: 27644734
[TBL] [Abstract][Full Text] [Related]
12. Non-dietary therapeutic clinical trials in coeliac disease.
Crespo Pérez L; Castillejo de Villasante G; Cano Ruiz A; León F
Eur J Intern Med; 2012 Jan; 23(1):9-14. PubMed ID: 22153524
[TBL] [Abstract][Full Text] [Related]
13. Nondietary Therapies for Celiac Disease.
Serena G; Kelly CP; Fasano A
Gastroenterol Clin North Am; 2019 Mar; 48(1):145-163. PubMed ID: 30711207
[TBL] [Abstract][Full Text] [Related]
14. Physiopathology and Management of Gluten-Induced Celiac Disease.
Kumar J; Kumar M; Pandey R; Chauhan NS
J Food Sci; 2017 Feb; 82(2):270-277. PubMed ID: 28140462
[TBL] [Abstract][Full Text] [Related]
15. Nutritional Consideration in Celiac Disease and Nonceliac Gluten Sensitivity.
Naik RD; Seidner DL; Adams DW
Gastroenterol Clin North Am; 2018 Mar; 47(1):139-154. PubMed ID: 29413009
[TBL] [Abstract][Full Text] [Related]
16. Celiac disease: Hope for new treatments beyond a gluten-free diet.
D'heedene M; Vanuytsel T; Wauters L
Clin Nutr; 2024 Jun; 43(6):1240-1249. PubMed ID: 38648685
[TBL] [Abstract][Full Text] [Related]
17. Evolving Therapy for Celiac Disease.
Yoosuf S; Makharia GK
Front Pediatr; 2019; 7():193. PubMed ID: 31157194
[TBL] [Abstract][Full Text] [Related]
18. Supplementation of Reduced Gluten Barley Diet with Oral Prolyl Endopeptidase Effectively Abrogates Enteropathy-Associated Changes in Gluten-Sensitive Macaques.
Sestak K; Thwin H; Dufour J; Liu DX; Alvarez X; Laine D; Clarke A; Doyle A; Aye PP; Blanchard J; Moehs CP
Nutrients; 2016 Jun; 8(7):. PubMed ID: 27367722
[TBL] [Abstract][Full Text] [Related]
19. Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease.
Croese J; Giacomin P; Navarro S; Clouston A; McCann L; Dougall A; Ferreira I; Susianto A; O'Rourke P; Howlett M; McCarthy J; Engwerda C; Jones D; Loukas A
J Allergy Clin Immunol; 2015 Feb; 135(2):508-16. PubMed ID: 25248819
[TBL] [Abstract][Full Text] [Related]
20. Celiac disease: a challenging disease for pharmaceutical scientists.
Matoori S; Fuhrmann G; Leroux JC
Pharm Res; 2013 Mar; 30(3):619-26. PubMed ID: 23229860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
